New study examines 'real-world' safety and efficacy of GLP-1 agonist and SGLT-2 inhibitor combo when used in elderly patients with suboptimal glycemic control
Health Canada re-affirmed recently that medical marijuana will continue after full legalization on Oct. 17. But the Canadian Medical Association said Sept. 26 that the group remains concerned about the lack of clinical research, guidance and regulatory oversight for medical cannabis.